Dr. Jason C. Lee
Claim this profileHoly Name Hospital
Studies Prostate Cancer
Studies Pancreatic Cancer
6 reported clinical trials
25 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
synaptophysin positive
chromogranin positive
2Pancreatic Cancer
BRCA1 positive
BRCA2 positive
PALB2 positive
Affiliated Hospitals
Clinical Trials Jason C. Lee is currently running
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Olaparib
for Pancreatic Cancer
This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been surgically removed (resected) and has a pathogenic mutation in BRCA1, BRCA2, or PALB2. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy.
Recruiting0 awards Phase 232 criteria
More about Jason C. Lee
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jason C. Lee has experience with
- Duloxetine
- Triptorelin
- Abiraterone
- Bicalutamide
- Degarelix
- Docetaxel
Breakdown of trials Jason C. Lee has run
Prostate Cancer
Pancreatic Cancer
Peripheral Neuropathy
Colorectal Cancer
Low Testosterone
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jason C. Lee specialize in?
Jason C. Lee focuses on Prostate Cancer and Pancreatic Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are synaptophysin positive.
Is Jason C. Lee currently recruiting for clinical trials?
Yes, Jason C. Lee is currently recruiting for 3 clinical trials in Teaneck New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Jason C. Lee has studied deeply?
Yes, Jason C. Lee has studied treatments such as Duloxetine, Triptorelin, Abiraterone.
What is the best way to schedule an appointment with Jason C. Lee?
Apply for one of the trials that Jason C. Lee is conducting.
What is the office address of Jason C. Lee?
The office of Jason C. Lee is located at: Holy Name Hospital, Teaneck, New Jersey 07666 United States. This is the address for their practice at the Holy Name Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.